Medicine References
Resources on Medications and Genomics
Useful
References and Resources for Pharmacogenomics (listed as title,
author(s),
journal citation, book publisher or website address)
Genome-wide
Approaches to Identifying Pharmacogenomics Contributors to Adverse Drug
Reactions.
Nelson,
M. R., S-A Bachnu, M. Mostellen, L. Li, C. E. Bowman, A. D. Roses, E.
H. Lai,
and M. G. Ehm.
Pharmacogenomics
Journal 9: 233-33, 2009
The
Clinical
Role of Genetic Polymorphisms in Drug-Metabolizing Enzymes.
Tomalik-Scharte,
D. et al.
Pharmacogenomics
Journal 8: 4-15. 2008
Prospective
Study of Grapefruit Intake and Risk of Breast Cancer in Post Menopausal
Women:
The Multiethnic Cohort Study.
Monroe,
KR.
Cancer
Res.
97:440-445. 2007
CYP2D6
Genotype,
Antidepressant use and Tamoxifen Metabolism during Adjuvant Breast
Cancer
Treatment.
Jin,
Y.
J.
Natl. Cancer Institute. 97:30-39. 2005
CYP2D6
polymorphisms
and the impact on tamoxifen therapy
Beverage
JN, TM Sissung, AM Sion, R Danesi and WD Figg
Journal
of Pharmacological Science 96: 2224-2231 (2007)
|
Pharmacogenetics
of Breast Cancer: Towards the Individualization of Therapy Chang
JC, SG Hilsenbeck, SAW Fuqua In
Pharmacogenetics
of Breast Cancer: Towards the Individualization of Therapy Edited
by BL Jones Informa
Healthcare New York
p 1-9 (2008). Incidence
of adverse drug reactions in hospitalized patients: a meta-analysis of
prospective studies. Lazarou
J, BH Pomerenz and PN Corey. Journal
of American Medical Association 279: 1200-1205 (1996). Use
of in vitro and in vivo data to estimate the likelihood of metabolic
pharmacokinetic interactions. Betz,
RJ and GR Granneman. Clinical
Pharmacokinetics 32: 210-258 (1997) http://www.medicine.iupui.edu/flockhart Drug
interaction tables organized by Cytochrome P450 enzyme and by drug
class with Pub Med-linked references for substrates, inhibitors and
inducers. Cytochrome
P450 2D6 activity predicts discontinuation of tamoxifen therapy in
breast cancer patients. Rae,
J, MJ Sikora, NL Henry, L Li, S Kim et al. The
Pharmacogenomics Journal 9:258-264 (2009) APOE
gene polymorphisms and response to statin therapy. Zintzaras,
E, GD Kitsios, F Triposkiadis, J Lau and G Raman The
Pharmacogenomics Journal 9: 248-259 (2009) Genetic
predictors of response to antidepressants in the GENDEP (Genome Based Therapeutic
Drugs for Depression) project. Uher,
R, P Huezo-Diaz, N Perroud, R Smith et al. The
Pharmacogenomics Journal 9: 225-233 (2009) |